Literature DB >> 885679

Marijuana and vision--after ten years' use in Costa Rica.

W W Dawson, C F Jiménez-Antillon, J M Perez, J A Zeskind.   

Abstract

Several tests of visual function were applied to an abstaining user (10 years or more) group and a nonuser group carefully preselected to be free of clinical signs of eye disease. The groups were matched on several criteria. The results show that all findings from both groups are within established limits of normalcy. Small differences and trends were found between the groups. These would have been undetected without large samples. Relative to the nonuser group, tests showed these user trends: increased basal lacrimation, increased intraocular pressure, increased photosensitivity, decreased dark adaptation, decreased color-match limits, and decreased Snellen acuity. These differences were associated with statistical probabilities, p=0.07 to p=0.001. There were no significant differences or clear trends between the user and nonuser groups in incidence of pathological fundus signs, conjunctival hyperemia, pterygia, or color-match midpoints.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 885679

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  15 in total

Review 1.  Synaptic transmission at retinal ribbon synapses.

Authors:  Ruth Heidelberger; Wallace B Thoreson; Paul Witkovsky
Journal:  Prog Retin Eye Res       Date:  2005-11       Impact factor: 21.198

2.  Endocannabinoid CB1 receptors modulate visual output from the thalamus.

Authors:  Miguel A Dasilva; Kenneth L Grieve; Javier Cudeiro; Casto Rivadulla
Journal:  Psychopharmacology (Berl)       Date:  2011-07-20       Impact factor: 4.530

3.  Contrast sensitivity and motion discrimination in cannabis users.

Authors:  Elena Mikulskaya; Frances Heritage Martin
Journal:  Psychopharmacology (Berl)       Date:  2018-06-16       Impact factor: 4.530

Review 4.  Tear analysis in contact lens wearers.

Authors:  R L Farris
Journal:  Trans Am Ophthalmol Soc       Date:  1985

5.  The Endocannabinoid System Is Present in Rod Outer Segments from Retina and Is Modulated by Light.

Authors:  Estefanía Chamorro Aguirre; Virginia L Gaveglio; Susana J Pasquaré
Journal:  Mol Neurobiol       Date:  2019-04-24       Impact factor: 5.590

6.  Ophthalmological assessment of cannabis-induced persisting perception disorder: is there a direct retinal effect?

Authors:  Ditta Zobor; Torsten Strasser; Gergely Zobor; Franziska Schober; Andre Messias; Olaf Strauss; Anil Batra; Eberhart Zrenner
Journal:  Doc Ophthalmol       Date:  2015-01-23       Impact factor: 2.379

Review 7.  Cannabinoids and glaucoma.

Authors:  I Tomida; R G Pertwee; A Azuara-Blanco
Journal:  Br J Ophthalmol       Date:  2004-05       Impact factor: 4.638

Review 8.  Endocannabinoids in the retina: from marijuana to neuroprotection.

Authors:  Stephen Yazulla
Journal:  Prog Retin Eye Res       Date:  2008-08-03       Impact factor: 21.198

Review 9.  TRPV1 and Endocannabinoids: Emerging Molecular Signals that Modulate Mammalian Vision.

Authors:  Daniel A Ryskamp; Sarah Redmon; Andrew O Jo; David Križaj
Journal:  Cells       Date:  2014-09-12       Impact factor: 6.600

10.  Cannabinoid Receptors CB1 and CB2 Modulate the Electroretinographic Waves in Vervet Monkeys.

Authors:  Joseph Bouskila; Vanessa Harrar; Pasha Javadi; Amy Beierschmitt; Roberta Palmour; Christian Casanova; Jean-François Bouchard; Maurice Ptito
Journal:  Neural Plast       Date:  2016-03-16       Impact factor: 3.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.